Exagen Inc.XGNNASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | -0.80% | +7.51% | +14.19% | +37.87% | +21.79% |
| Gross Profit Growth | +4.08% | +6.11% | +14.79% | +44.32% | +8.60% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +2.06% | +3.42% | +15.99% | +25.23% | +18.43% |
| Weighted Average Shares Diluted Growth | +2.06% | +3.42% | +15.99% | +25.67% | +18.43% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -95.65% | +0.00% | +0.00% | +0.00% | -930.03% |
| Free Cash Flow Growth | -97.37% | +0.00% | +0.00% | +0.00% | -1508.76% |
| Receivables Growth | +19.60% | +35.11% | +31.62% | +18.16% | +38.54% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | -21.52% | -20.69% | +19.17% | +44.07% | +29.84% |
| Book Value per Share Growth | -58.81% | -69.03% | +3.12% | +12.55% | +54.44% |
| Debt Growth | -0.97% | -0.17% | +5.56% | +19.59% | +20.26% |
| R&D Expense Growth | +53.90% | +21.25% | +25.78% | +16.81% | +6.10% |
| SG&A Expenses Growth | -16.47% | +6.28% | +10.30% | +12.61% | +21.76% |